The breast cancer information core: database design, structure, and scope
- PMID: 10923033
- DOI: 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y
The breast cancer information core: database design, structure, and scope
Abstract
The Breast Cancer Information Core (BIC) is an open access, on-line mutation database for breast cancer susceptibility genes. In addition to creating a catalogue of all mutations and polymorphisms in breast cancer susceptibility genes, a principle aim of the BIC is to facilitate the detection and characterization of these genes by providing technical support in the form of mutation detection protocols, primer sequences, and reagent access. Additional information at the site includes a literature review compiled from published studies, links to other internet-based, breast cancer information and research resources, and an interactive discussion forum which enables investigators to post or respond to questions and/or comments on a bulletin board. Hum Mutat 16:123-131, 2000. Published 2000 Wiley-Liss, Inc.
Similar articles
-
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.Hum Mutat. 2003 Aug;22(2):121-8. doi: 10.1002/humu.10238. Hum Mutat. 2003. PMID: 12872252
-
BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.Br J Cancer. 2000 Sep;83(6):737-42. doi: 10.1054/bjoc.2000.1332. Br J Cancer. 2000. PMID: 10952777 Free PMC article.
-
A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.Cas Lek Cesk. 2000 Oct 11;139(20):635-7. Cas Lek Cesk. 2000. PMID: 11192759
-
Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.Eur J Cancer Prev. 2000 Jun;9(3):139-50. Eur J Cancer Prev. 2000. PMID: 10954253 Review.
-
Hereditary breast cancer: a review.Semin Cancer Biol. 2000 Aug;10(4):271-88. doi: 10.1006/scbi.2000.0325. Semin Cancer Biol. 2000. PMID: 10966850 Review.
Cited by
-
BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage.Mol Cell Biol. 2004 Sep;24(17):7444-55. doi: 10.1128/MCB.24.17.7444-7455.2004. Mol Cell Biol. 2004. PMID: 15314155 Free PMC article.
-
Selection and the cell cycle: positive Darwinian selection in a well-known DNA damage response pathway.J Mol Evol. 2010 Dec;71(5-6):444-57. doi: 10.1007/s00239-010-9399-y. Epub 2010 Nov 4. J Mol Evol. 2010. PMID: 21057781
-
Functional assays for analysis of variants of uncertain significance in BRCA2.Hum Mutat. 2014 Feb;35(2):151-64. doi: 10.1002/humu.22478. Epub 2013 Dec 3. Hum Mutat. 2014. PMID: 24323938 Free PMC article. Review.
-
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.Breast Cancer Res Treat. 2015 Sep;153(2):435-43. doi: 10.1007/s10549-015-3545-6. Epub 2015 Aug 22. Breast Cancer Res Treat. 2015. PMID: 26296701 Free PMC article.
-
Identification of Medically Actionable Secondary Findings in the 1000 Genomes.PLoS One. 2015 Sep 2;10(9):e0135193. doi: 10.1371/journal.pone.0135193. eCollection 2015. PLoS One. 2015. PMID: 26332594 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical